10.1093/brain/awl217 168 PenderisJ.ShieldsS
It is even possible that the insulin-stimulating, glucagon-suppressing effects of the peptide or a more active synthetic analogue may be useful in the treatment of non-insulin-dependent diabetes, in which both impaired insulin release in response to glucose and persistent hyperglucagonemia are thought to be key pathophysiological abnormalities' (Kreymann, Ghattei, Williams, Bloom)
Usage Directions: You must read the Directions to Use section on the product as this will help you understand the right way of consuming it
View at PubMed Falutz J, Allas S, Blot K, et al
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin
More serious risks include pancreatitis, gallbladder disease, and potential thyroid C-cell tumors (observed in rodent studies)